Safety, Tolerability and Efficacy of Tirbanibulin Ointment 1% Treatment on 100 Cm2 of the Face and Scalp in Patients With Actinic Keratosis: A Phase 3 Study. J of Skin 2023, 7 (6), s264. https://doi.org/10.25251/skin.7.supp.264.